The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

High-profile discussion is linked to a spike in diagnoses in what is now England's commonest cancer type.

While prostate cancer is becoming more prevalent among middle-aged and elderly men in China, clinical practice still faces considerable challenges due to the lack of unified guidelines and high ...

ASCO 2023: Timing of PARP Inhibition for Prostate Cancer with Defects in Homologous Recombination Repair ASCO 2023: A Multi-Center Natural History Study of Precision-Based Genomics in Prostate Cancer ...

Black people are twice as likely to die of prostate, stomach and uterine cancers compared with White people and 50% more likely to die from preventable cervical cancer. The report also found that ...

A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time ... head and neck, stomach, prostate and non-small cell lung cancers. Dr Tan Yu ...

Now available with the official launch of ProstaVive, it addresses what experts call a hidden “clog” in the prostate, delivering comprehensive support for circulation, detoxification ...

In April 2024, the Prostate Cancer Foundation (PCF) tried to help close the gap by issuing new guidelines, published in NEJM Evidence, recommending that Black men consider PSA screening starting ...

The face of cancer in the U.S. is getting younger—and more feminine. Cancer rates for women in the U.S. have risen over the past half-century, particularly among women under age 65 diagnosed ...

Charmella Roark remembers the shock that stopped her in her tracks when she learned about her younger sister’s cancer diagnosis ... as White people’s for prostate, stomach and uterine corpus ...

In Massachusetts, the report shows that the highest number of expected new cancer cases for 2025 are breast cancer, followed by prostate cancer and lung cancer. Lung cancer, colorectal cancer, and ...